Ask a Question
Coherent

Search Results

Refine

Result Type

13 - 24 of 136 Products for 'espp' Page 2 of 12 |

espp

COHR AR2007 final.qxd

COHR AR2007 final.qxd

…expense ratably over the respective vesting period. The ESPP qualified as a non compensatory plan under APB 25; therefore, no compensation cost was recorded in relation to the discount offered to employees for purchases made under the ESPP. Effective October 2, 2005, we adopted the fair value…

COHR AR2007

COHR AR2007

…issuance under the plan. In the second quarter of fiscal 2007, the ESPP was suspended and employee contributions made to the ESPP were returned while a voluntary review of our historical stock option practices was conducted. The ESPP was reopened on March 2, 2008 with an 8 month offering period…

COHR AR2007 final.qxd

…expense ratably over the respective vesting period. The ESPP qualified as a noncompensatory plan under APB 25; therefore, no compensation cost was recorded in relation to the discount offered to employees for purchases made under the ESPP. Effective October 2, 2005, we adopted the fair value…

COHR AR2007

…issuance under the plan. In the second quarter of fiscal 2007, the ESPP was suspended and employee contributions made to the ESPP were returned while a voluntary review of our historical stock option practices was conducted. The ESPP was reopened on March 2, 2008 with an 8 month offering period…

COHR AR2007 final.qxd

COHR AR2007 final.qxd

…with the provisions of SFAS 123(R). Total pretax compensation cost for our option and ESPP plans in 2007 was $7.4 million and $1.3 million, respectively. Total pretax compensation cost for our option and ESPP plans in 2006 was $10.5 million and $1.4 million, respectively. Total pretax compensation…

COHR AR2007 final.qxd

COHR AR2007 final.qxd

…with the provisions of SFAS 123(R). Total pretax compensation cost for our option and ESPP plans in 2007 was $7.4 million and $1.3 million, respectively. Total pretax compensation cost for our option and ESPP plans in 2006 was $10.5 million and $1.4 million, respectively. Total pretax compensation…

2009AnnualReport.pdf

2009AnnualReport.pdf

…issuance under the plan. In the second quarter of fiscal 2007, the ESPP was suspended and employee contributions made to the ESPP were returned while a voluntary review of our historical stock option practices was conducted. The ESPP was reopened on March 2, 2008 with an 8 month offering period…

COHR AR2007 final.qxd

…with the provisions of SFAS 123(R). Total pretax compensation cost for our option and ESPP plans in 2007 was $7.4 million and $1.3 million, respectively. Total pretax compensation cost for our option and ESPP plans in 2006 was $10.5 million and $1.4 million, respectively. Total pretax compensation…

2009AnnualReport

…issuance under the plan. In the second quarter of fiscal 2007, the ESPP was suspended and employee contributions made to the ESPP were returned while a voluntary review of our historical stock option practices was conducted. The ESPP was reopened on March 2, 2008 with an 8 month offering period…

9.28.2013 10K

…changes in estimated forfeitures. At fiscal 2013 year-end, the total compensation cost related to options to purchase common shares under the ESPP but not yet recognized was approximately $0.1 million. This cost will be amortized on a straight-line basis over a weighted-average period of…

Q1-12.29.2013-10Q

…subsequent changes in estimated forfeitures. At December 29, 2012, total compensation cost related to options to purchase common shares under the ESPP but not yet vested was approximately $0.6 million, which will be recognized over the six month offering period. The stock option exercise tax…

9.29.2012 10K

…changes in estimated forfeitures. At fiscal 2012 year-end, the total compensation cost related to options to purchase common shares under the ESPP but not yet recognized was approximately $0.1 million. This cost will be amortized on a straight-line basis over a weighted-average period of…

Powered by Site Search powered by SLI Systems

Please Read Before Continuing

Risk factors: Except for the historical information contained here, many of the matters discussed in this Web site are forward-looking statements, based on expectations at the time they were made, that involve risks and uncertainties that could cause our results to differ materially from those expressed or implied by such statements. These risks are detailed in the “Factors That May Affect Future Results” section of our latest 10-K or 10-Q filing. Coherent assumes no obligation to update these forward-looking statements.


I have read the terms and conditions